Vertex Pharmaceuticals Incorporated - NASDAQGS:VRTX - Comprehensive analysis
Free evaluation through quantitative algorithms Vertex Pharmaceuticals Incorporated - NASDAQGS:VRTX
Growth-Scoring Model Detail
Total Revenue Growth Over Prior Year | 11.66 | Market 79 Sector 66 |
Gross Profit Growth Over Prior Year | 10.25 | Market 68 Sector 63 |
EBITDA Growth Over Prior Year | 6.65 | Market 50 Sector 55 |
EBITA Growth Over Prior Year | 7.05 | Market 53 Sector 50 |
EBIT Growth Over Prior Year | 6.62 | Market 47 Sector 48 |
Earnings from Cont. Ops. Growth Over Prior Year | 0 | Market 0 Sector 0 |
Net Income Growth Over Prior Year | 0 | Market 0 Sector 0 |
Normalized Net Income Growth Over Prior Year | 4.54 | Market 47 Sector 37 |
Diluted EPS before Extra Growth Over Prior Year | 0 | Market 0 Sector 0 |
A/R Growth Over Prior Year | 2.94 | Market 54 Sector 62 |
Inventory Growth Over Prior Year | 64 | Market 100 Sector 97 |
PPE Net Growth Over Prior Year | 78 | Market 100 Sector 94 |
Total Assets Growth Over Prior Year | -0.87 | Market 29 Sector 46 |
Tangible Book Value Growth Over Prior Year | -7.39 | Market 14 Sector 46 |
Common Equity Growth Over Prior Year | -6.66 | Market 15 Sector 46 |
Cash from Ops. Growth Over Prior Year | 0 | Market 0 Sector 0 |
CAPEX Growth Over Prior Year | 48.6 | Market 94 Sector 85 |
Dividend per Share Growth Over Prior Year | 0 | Market 36 Sector 48 |
Levered Free Cash Flow Growth Over Prior Year | -22.35 | Market 17 Sector 23 |
Unlevered Free Cash Flow Growth Over Prior Year | -22.42 | Market 17 Sector 22 |
Profitability-Scoring Model Detail
Gross Margin % | 87 | Market 97 Sector 86 |
SG&A Margin % | 12.99 | Market 47 Sector 29 |
EBITDA Margin % | 43.3 | Market 83 Sector 98 |
EBITA Margin % | 41.9 | Market 94 Sector 98 |
EBIT Margin % | 41.7 | Market 94 Sector 99 |
Earnings from Cont. Ops Margin % | -4.86 | Market 3 Sector 39 |
Net Income Margin % | -4.86 | Market 4 Sector 39 |
Net Income Avail. for Common Margin % | -4.86 | Market 3 Sector 39 |
Normalized Net Income Margin % | 28.8 | Market 98 Sector 99 |
Levered Free Cash Flow Margin % | 24.7 | Market 85 Sector 95 |
Unlevered Free Cash Flow Margin % | 24.9 | Market 82 Sector 94 |
Return on Assets % | 12.68 | Market 90 Sector 97 |
Return on Capital % | 15.71 | Market 84 Sector 96 |
Return on Equity % | -3.15 | Market 4 Sector 73 |
Return on Common Equity % | -3.15 | Market 4 Sector 73 |
Total Asset Turnover | 0.49 | Market 48 Sector 62 |
